Publications by authors named "Hooman A"
Article Synopsis
- The keratocystic odontogenic tumor (KCOT) is a benign tumor that tends to recur, and there is ongoing debate about the best treatment methods to manage it effectively.
- A review of studies from 2010 to 2020 included various treatment options such as decompression, marsupialization, and resection, with recurrence rates varying significantly.
- The article emphasizes the importance of long-term follow-up care post-treatment and suggests treatment decisions should consider the patient's age, tumor size, and location to minimize both financial and emotional impacts.
99mTc-sestamibi has been investigated as a potential viability marker; initial studies have shown good concordance between 201Tl and 99mTc-sestamibi activities in both viable and nonviable myocardium. However, assessment of myocardial viability by 99mTc-sestamibi remains controversial for tissue recovery after revascularization. Here, we present a patient with several regions of severely diminished and irreversible (defect persisting in both early and delay images of each set scanning) defects on initial scan which were dissolved completely on the follow up scan after an intervention.
View Article and Find Full Text PDFUnlabelled: Diabetic foot infection is the most common etiology of nontraumatic amputation of the lower extremities, and early diagnosis is of great importance in its management. The aim of this prospective study was to evaluate the strength of (99m)Tc-IgG scintigraphy in diagnosis of osteomyelitis of the diabetic foot and to compare (99m)Tc-IgG scintigraphy with (99m)Tc-methylene diphosphonate (MDP) scintigraphy.
Methods: A prospective university hospital-based study was performed over 24 mo.
Introduction: This study was performed to determine the clinical application of rest 99mTc-sestamibi in the assessment of viability and functional improvement of the left ventricle (LV) myocardium in the post-thrombolytic therapy of acute myocardial infarction (AMI).
Material And Methods: In 37 patients with AMI who received thrombolytic therapy, 2-dimensional (2D) echocardiography, as well as the resting redistribution of 99mTc-sestamibi, was investigated, both within 1 week and 3-5 months after AMI. The predictive capacity of the perfusion percentage for myocardial function recovery was evaluated.
Article Synopsis
- Dipyridamole is commonly used as an alternative to physical exercise in assessing cardiovascular health, and this study examined its side effects in relation to heart function and imaging results.
- A total of 590 patients were monitored during dipyridamole infusion for vital signs and ECG changes, finding that 14.9% experienced side effects such as chest discomfort and headaches, which correlated with certain hemodynamic changes.
- Results indicated that while there was a link between side effects and heart rate/blood pressure fluctuations, there was no significant relationship between these side effects and abnormal imaging or ECG findings.
Objective: We evaluated the potential detrimental cytogenetic effects of Tc-methoxyisobutyl isonitrile (MIBI) and I on patients who were exposed to the radiopharmaceutics for cardiac imaging or thyroid cancer therapy, respectively.
Methods: Mononuclear leukocytes were isolated both before and after radiopharmaceutical administration and subsequently cultured. Micronuclei frequency was then assessed and microscopic evaluation of apoptosis was conducted.